Related references
Note: Only part of the references are listed.MicroRNA-30a-3p is overexpressed in the placentas of patients with preeclampsia and affects trophoblast invasion and apoptosis by its effects on IGF-1
Zi-Ru Niu et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2018)
Potential value of circulating microRNA-126 and microRNA-210 as biomarkers for type 2 diabetes with coronary artery disease
K. S. Amr et al.
BRITISH JOURNAL OF BIOMEDICAL SCIENCE (2018)
MiR-155-5p controls colon cancer cell migration via post-transcriptional regulation of Human Antigen R (HuR)
Amr Al-Haidari et al.
CANCER LETTERS (2018)
A study of circulating microRNAs identifies a new potential biomarker panel to distinguish aggressive prostate cancer
Batoul Farran et al.
CARCINOGENESIS (2018)
The Double Face of Exosome-Carried MicroRNAs in Cancer Immunomodulation
Romina Alfonsi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
被撤回的出版物: microRNA-136 inhibits proliferation and promotes apoptosis and radiosensitivity of cervical carcinoma through the NF-κB pathway by targeting E2F1 (Retracted article. See vol. 305, 2022)
Hong-Jie Lu et al.
LIFE SCIENCES (2018)
microRNAs in the haemostatic system: More than witnesses of thromboembolic diseases?
Ana B. Arroyo et al.
THROMBOSIS RESEARCH (2018)
miR-181a-5p suppresses invasion and migration of HTR-8/SVneo cells by directly targeting IGF2BP2
Liang Wu et al.
CELL DEATH & DISEASE (2018)
Hirschsprung's disease: clinical dysmorphology, genes, micro-RNAs, and future perspectives
Consolato Maria Sergi et al.
PEDIATRIC RESEARCH (2017)
MicroRNA-616 promotes the growth and metastasis of non- small cell lung cancer by targeting SOX7
Danping Wang et al.
ONCOLOGY REPORTS (2017)
Hypomethylation of tissue factor pathway inhibitor 2 in human placenta of preeclampsia
Xirong Xiao et al.
THROMBOSIS RESEARCH (2017)
The IncRNA TUG1 modulates proliferation in trophoblast cells via epigenetic suppression of RND3
Yetao Xu et al.
CELL DEATH & DISEASE (2017)
被撤回的出版物: miR-3174 Contributes to Apoptosis and Autophagic Cell Death Defects in Gastric Cancer Cells by Targeting ARHGAP10 (Retracted article. See vol. 28, pg. 591, 2022)
Bowen Li et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Methylation of tissue factor pathway inhibitor 2 as a prognostic biomarker for hepatocellular carcinoma after hepatectomy
Feng-Kai Sun et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Pathogenesis of preeclampsia
Monica Sircar et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2015)
Deregulated microRNA species in the plasma and placenta of patients with preeclampsia
Sheng Yang et al.
MOLECULAR MEDICINE REPORTS (2015)
Low-Dose Aspirin for Prevention of Morbidity and Mortality From Preeclampsia: A Systematic Evidence Review for the US Preventive Services Task Force
Jillian T. Henderson et al.
ANNALS OF INTERNAL MEDICINE (2014)
Strategy for Standardization of Preeclampsia Research Study Design
Leslie Myatt et al.
HYPERTENSION (2014)
MiR-101 regulates apoptosis of trophoblast HTR-8/SVneo cells by targeting endoplasmic reticulum (ER) protein 44 during preeclampsia
Y. Zou et al.
JOURNAL OF HUMAN HYPERTENSION (2014)
Syncytiotrophoblast Vesicles Show Altered micro-RNA and Haemoglobin Content after Ex-vivo Perfusion of Placentas with Haemoglobin to Mimic Preeclampsia
Tina Cronqvist et al.
PLOS ONE (2014)
Human Placental MicroRNAs and Preeclampsia
Dong-bao Chen et al.
BIOLOGY OF REPRODUCTION (2013)
A leading role for the immune system in the pathophysiology of preeclampsia
Estibalitz Laresgoiti-Servitje
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Role of epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma: is tumor budding the missing link?
Eva Karamitopoulou
FRONTIERS IN ONCOLOGY (2013)
Epigenetic control of epithelial-mesenchymal-transition in human cancer
Tobias Kiesslich et al.
MOLECULAR AND CLINICAL ONCOLOGY (2013)
Effects of Tissue Factor Pathway Inhibitor-2 Expression on Biological Behavior of BeWo and JEG-3 Cell Lines
Qiongjie Zhou et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2012)
MiRNAs and Their Association with Locoregional Staging and Survival Following Surgery for Esophageal Carcinoma
Richard Hummel et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
MicroRNA-616 Induces Androgen-Independent Growth of Prostate Cancer Cells by Suppressing Expression of Tissue Factor Pathway Inhibitor TFPI-2
Stephanie Ma et al.
CANCER RESEARCH (2011)
miRNA expression profiling in formalin-fixed and paraffin-embedded placental tissue samples from pregnancies with severe preeclampsia
Frank Noack et al.
JOURNAL OF PERINATAL MEDICINE (2011)
Tissue factor pathway inhibitor-2 is downregulated by ox-LDL and inhibits ox-LDL induced vascular smooth muscle cells proliferation and migration
Bilian Zhao et al.
THROMBOSIS RESEARCH (2011)
TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma
Shumin Wang et al.
BMC CANCER (2010)
MiR-148a Attenuates Paclitaxel Resistance of Hormone-refractory, Drug-resistant Prostate Cancer PC3 Cells by Regulating MSK1 Expression.
Yasunori Fujita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Changes of plasma and placental tissue factor pathway inhibitor-2 in women with preeclampsia and normal pregnancy
Yu Xiong et al.
THROMBOSIS RESEARCH (2010)
Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies
Xiao-ming Zhu et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2009)
The role of tissue factor pathway inhibitor-2 in cancer biology
Ewa Sierko et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2007)
Identification of a human TFPI-2 splice variant that is upregulated in human tumor tissues
Prakasha Kempaiah et al.
MOLECULAR CANCER (2007)
Preeclampsia: Diagnosis and management of the atypical presentation
Caroline L. Stella et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2006)
Share Paper
